Residents of Komi will be able to pass an antibiotic resistance test n

Residents of Komi were told about a test to detect a gene for resistance to methicillin - mecA. This gene makes bacteria immune to beta-lactam antibiotics.

The test is designed to analyze cerebrospinal fluid in patients with suspected infections caused by resistant bacteria. This is the world’s first registered medical device for the diagnosis of antibiotic resistance based on CRISPR/Cas.

The main advantage is high sensitivity, comparable to PCR. This is important for early diagnosis of infections. Double specificity control ensures the reliability of the analysis in complex clinical conditions.